Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Join a 58-minute webinar led by renowned physician-scientist Dr. Iman Osman exploring the innovative use of autoantibody profiling to predict treatment outcomes in melanoma patients. Discover how to navigate the challenges of immune-related adverse events caused by immune checkpoint inhibitors, understand the strategic approach to autoantibody profiling for biomarker identification, and examine the validation process of these groundbreaking biomarkers. Learn about promising results that could transform melanoma treatment approaches and explore future research directions in this field. Gain valuable insights into antibody profiling's broader applications in medical research while earning PACE credits valid through October 2026. Drawing from Dr. Osman's extensive experience leading the NYU Interdisciplinary Melanoma Cooperative Group and managing over 110,000 biospecimen samples, explore cutting-edge developments in personalized cancer therapy through the lens of autoantibody biomarker research.
